Home > Executive Order

AI Summary: This is a policy document, specifically an Executive Order modifying duties related to the synthetic opioid supply chain from China. This regulation reduces the additional ad valorem rate of duty on Chinese products from 20% to 10%, effective November 10, 2025, in response to China's commitment to take steps to end the flow of fentanyl to the United States. The order stems from previous executive orders declaring a national emergency regarding synthetic opioids, and it outlines the reduction of tariffs based on China's pledged measures to control chemical exports and stop shipments of designated chemicals to North America. The document provides detailed instructions for implementing the tariff reduction, including modifications to the Harmonized Tariff Schedule of the United States, and establishes ongoing monitoring requirements for the Secretary of Homeland Security to track China's compliance with its commitments. The order also includes provisions for potential future actions if China fails to implement its promised measures and provides delegations of authority to the Secretary of Homeland Security to take necessary actions to implement the order.